Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease

Journal of Nuclear Medicine

Volumn 38, Issue 3, 1997, Pages 428-432

  Münch, Götz ^a   Neverve, Jodi ^a   Matsunari, Ichiro ^a   Schröter, Gerrit ^a   Schwaiger, Markus ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Liver clearance; Myocardial uptake; Technetium 99m sestamibi; Technetium 99m tetrofosmin

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG CLEARANCE; DRUG HALF LIFE; DRUG UPTAKE; FEMALE; HUMAN; LIVER CLEARANCE; MALE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; TREADMILL EXERCISE;

CORONARY DISEASE; EXERCISE TEST; FEMALE; HALF-LIFE; HEART; HUMANS; LIVER; MALE; MIDDLE AGED; MYOCARDIUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 1842288027     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Zaret BL, Wackers FJ. Nuclear cardiology. N Engl J Med 1993;329:775-783.
2. Zaret BL, Wackers FJ. Nuclear cardiology. N Engl J Med 1993;329:855-863.
3. Beller GA. Myocardial perfusion imaging with thallium-201. J Nucl Med 1994;35: 674-680.
4. Nakajima K, Taki J, Bunko H, et al. Dynamic acquisition with a three-headed SPECT system: application to technetium-99m-SQ30217 myocardial imaging. J Nucl Med 1991;32:1273-1277.
5. Leppo JA, DePuey EG, Johnson LL. A review of cardiac imaging with sestamibi and teboroxime. J Nucl Med 1991;32:2021-2022.
6. Wackers FJT, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301-311.
7. Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-227.
8. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-38.
9. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m-tetrofosmin J Nucl Med 1993; 34:1478-1484.
10. Jain D, Wackers FJ, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993;34:1254-1259.
11. Sinusas AJ, Shi Q, Saltzberg MT, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35:664-671.
12. Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium-99tn-tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography. J Nucl Med 1994;35:587-593.
13. 201Tl imaging and coronary angiography in a Phase III multicenter trial. Tetrofosmin International Trial Study Group. Circulation 1995;91: 313-319.
14. Tamaki N, Takahashi N, Kawamoto M, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994;35:594-600.
15. Flamen P, Bossuyt A, Franken PR. Technetium-99m-tetrofosmin in dipyridamol-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi. J Nucl Med 1995;36:2009-2015.
16. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 1990;82:1826-1838.
17. Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-99m-tetrofosmin. I. uptake into isolated adult rat ventricular myocytes and subcelluar localization. J Nucl Cardiol 1995;2:317-326.
18. Younes A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-99m-tetrofosmin. II. Uptake into isolated adult rat heart mitochondria. J Nucl Cardiol 1995;2:327-333.
19. Piwinca-Worms D, Kronauge JF, Holmann BL, Davison A, Jones AG. Comparative myocardial uptake characteristics of hexakis (alkylisonitrile)technetium(I) complexes: effect of lipophilicity. Invest Radiol 1989;24:25-29.
20. Wolfe CL, O'Connell JW, Sievers RE, Cobb C, Dae MW, Botvinick E. Assessment of perfused left ventricular mass in normal, ischemic and reperfused myocardium by means of SPECT of technetium-99m isonitrile. Am Heart J 1993;126:1275-1286.
21. 99mTc-MIBI in canine myocardium after dipyridamole. Circulation 1990;81:628-637.
22. 99mTc-MIBI: comparison of short and long time intervals between rest and stress injections. Eur J Nucl Med 1988;13:515-522.